Global Health Limited (ASX:GLH)
Australia · Delayed Price · Currency is AUD 0.0500
0.00 (0.00%)
Sep 9, 2026, 9:59 AM AEST
Global Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 7.18 | 7.32 | 8.12 | 7.82 | 6.54 |
Other Revenue | 0.83 | 1.35 | 0.54 | - | - |
| 8.02 | 8.67 | 8.66 | 7.82 | 6.54 | |
Revenue Growth | -7.48% | 0.08% | 10.75% | 19.61% | -7.01% |
Cost of Revenue | 5.92 | 6.57 | 6.12 | 7.31 | 6.6 |
Gross Profit | 2.1 | 2.1 | 2.54 | 0.51 | -0.06 |
Selling, General & Admin | 0.8 | 0.74 | 1.02 | 1.51 | 1.32 |
Research & Development | 1.82 | 2.1 | 2.69 | 2.21 | 0.31 |
Amortization of Goodwill & Intangibles | - | - | - | 0.48 | 0.28 |
Operating Expenses | 2.67 | 2.9 | 3.76 | 4.24 | 1.91 |
Operating Income | -0.57 | -0.8 | -1.23 | -3.73 | -1.98 |
Interest Expense | -0.11 | -0.11 | -0.03 | -0 | -0 |
Interest & Investment Income | 0.01 | 0.03 | 0.01 | 0 | 0 |
Currency Exchange Gain (Loss) | -0.02 | -0.01 | -0.02 | -0.06 | -0.01 |
Other Non Operating Income (Expenses) | -0.07 | 0.02 | -0.05 | -0.01 | -0.03 |
EBT Excluding Unusual Items | -0.76 | -0.87 | -1.31 | -3.8 | -2.01 |
Asset Writedown | - | - | - | -3.9 | - |
Pretax Income | -0.76 | -0.87 | -1.31 | -7.7 | -2.01 |
Income Tax Expense | - | - | - | 0.35 | 0.04 |
Earnings From Continuing Operations | -0.76 | -0.87 | -1.31 | -8.05 | -2.05 |
Net Income | -0.76 | -0.87 | -1.31 | -8.05 | -2.05 |
Net Income to Common | -0.76 | -0.87 | -1.31 | -8.05 | -2.05 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 59 | 58 | 58 | 58 | 56 |
Shares Outstanding (Diluted) | 59 | 58 | 58 | 58 | 56 |
Shares Change | 0.87% | 0.27% | 0.92% | 2.71% | 32.20% |
EPS (Basic) | -0.01 | -0.01 | -0.02 | -0.14 | -0.04 |
EPS (Diluted) | -0.01 | -0.01 | -0.02 | -0.14 | -0.04 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -0.09 | -0.71 | -1.15 | -3.47 | -1.19 |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.06 | -0.02 |
Gross Margin | 26.17% | 24.21% | 29.31% | 6.54% | -0.99% |
Operating Margin | -7.11% | -9.25% | -14.15% | -47.70% | -30.23% |
Profit Margin | -9.46% | -10.00% | -15.15% | -103.03% | -31.35% |
Free Cash Flow Margin | -1.16% | -8.15% | -13.29% | -44.40% | -18.21% |
EBITDA | -0.56 | -0.79 | -1.22 | -3.72 | -1.97 |
EBITDA Margin | -6.98% | -9.15% | -14.09% | -47.63% | -30.18% |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
EBIT | -0.57 | -0.8 | -1.23 | -3.73 | -1.98 |
EBIT Margin | -7.11% | -9.25% | -14.15% | -47.70% | -30.23% |
Revenue as Reported | 8.03 | 8.7 | 8.67 | 7.82 | 6.54 |